ISRG Stock Recent News

Surgical robots firm Intuitive Surgical said exports to and imports from China are subject to high tariffs. Shares are rising Wednesday on hopes the trade war will de-escalate.

Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q1 2025 Earnings Conference Call April 22, 2025 4:30 AM ET Company Participants Dan Connally - Head of IR Gary Guthart - CEO David Rosa - President Jamie Samath - CFO Daniel Oh - Senior Medical Officer Conference Call Participants Travis Steed - Bank of America Securities Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Rick Wise - Stifel Adam Maeder - Piper Sandler Ryan Zimmerman - BTIG David Roman - Goldman Sachs Operator Thank you for standing by, and welcome to the Intuitive Surgical, Inc.'s First Quarter 2025 Earnings Release. [Operator Instructions] As a reminder, today's program is being recorded.

Although the revenue and EPS for Intuitive Surgical (ISRG) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.50 per share a year ago.

Intuitive Surgical raised concerns on Tuesday about the potential impact of tariffs on its annual results, despite exceeding Wall Street's first-quarter profit and revenue estimates.

SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2025.

The Investment Committee give you their top stocks to watch for the second half.

Intuitive Surgical Inc ISRG will report its first-quarter earnings after the market closes on Tuesday. Wall Street expects earnings per share of $1.72 and revenue of $2.19 billion for the quarter.

Intuitive Surgical's first-quarter results are likely to reflect solid performance in the company???s Instruments & Accessories segment.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.